Kellerhals Carrard advised Groupe Minoteries on its takeover of the traditional Schweizerische Schälmühle E. Zwicky. The context Pursuant to the transaction, the long-term succession of the Klopfenstein family will be preserved and the
Tags :Kellerhals Carrard
Swiss precision medicines company Haya Therapeutics completed a $65 million series A funding round. In connection with the deal, Kellerhals Carrard represented lead investors Sofinnova Partners and Earlybird Venture Capital, while Lenz & Staehelin assisted Eli
Kellerhals Carrard advised Vaud-based start-up NovaMea and its founder Xile Hu in connection with a 9M USD series A financing round. The context Several international VCs led the capital round in question, with all proceeds
Kellerhals Carrard advised Basel-based CGC Genomics Consults on all legal aspects of their pre-seed financing round. Pursuant to the transaction, the Swiss startup secured approximately EUR 1.7 million. The context Several impact and health-tech investors led
Banking & Finance Baker McKenzie advised UBS Switzerland and a syndicate of Swiss banks on the conclusion of a syndicated credit facility agreement for Mercedes-Benz Automobil (Merbag). The proceeds of the facility in question will
Kellerhals Carrard advised Burgdorf-based TecMed as lead counsel on the company’s acquisition of Ypsomed’s diabetes care business for CHF 420 million, including earn-out. Moreover, Walder Wyss represented the selling part throughout the transaction. Closing
Welcome to Signed Sealed Weekend, our inside track into the Swiss legal scene. This week we anticipate our recap to Thursday, as we’re approaching the Easter weekend and we start-off with our banking &
Kellerhals Carrard advised the selling part in the sale of all the shares in Senn Chemicals to Granules India. Moreover, Loyens & Loeff represented Granules India throughout the operation. The parties signed the deal in
French automotive distributor BPM completed the acquisition of Renens-based Groupe Leuba. In connection with the deal, Borel & Barbey represented the buyer, while Kellerhals Carrard advised the shareholders of Groupe Leuba. The parties Headquartered in
Kellerhals Carrard advised Bloom Biorenewables in connection with the closing of its CHF 13M Series A financing round. The investors Anaïs Ventures and Valquest Partners led the capital round in question, with further participation
